

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.74277590 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.37776038 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.92867400 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 4.92867400 |
| 5 | respiratory electron transport chain (GO:0022904) | 4.92038220 |
| 6 | electron transport chain (GO:0022900) | 4.85002780 |
| 7 | immunoglobulin mediated immune response (GO:0016064) | 4.80410247 |
| 8 | succinate metabolic process (GO:0006105) | 4.73086452 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.68163175 |
| 10 | protein complex biogenesis (GO:0070271) | 4.65781284 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.54343705 |
| 12 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.25431999 |
| 13 | oxaloacetate metabolic process (GO:0006107) | 4.25198370 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.15855367 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.98067726 |
| 16 | B cell mediated immunity (GO:0019724) | 3.95548402 |
| 17 | dopamine transport (GO:0015872) | 3.95491700 |
| 18 | chaperone-mediated protein transport (GO:0072321) | 3.85971133 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.81123778 |
| 20 | protein localization to cilium (GO:0061512) | 3.74025705 |
| 21 | positive regulation of B cell differentiation (GO:0045579) | 3.70822004 |
| 22 | regulation of oxidative phosphorylation (GO:0002082) | 3.66435584 |
| 23 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.61800934 |
| 24 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.57137360 |
| 25 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.57137360 |
| 26 | NADH dehydrogenase complex assembly (GO:0010257) | 3.57137360 |
| 27 | neuromuscular process controlling posture (GO:0050884) | 3.55903618 |
| 28 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.51795713 |
| 29 | DNA deamination (GO:0045006) | 3.50288247 |
| 30 | neuron cell-cell adhesion (GO:0007158) | 3.49839880 |
| 31 | negative regulation of cell killing (GO:0031342) | 3.49233527 |
| 32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.49233527 |
| 33 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.48968841 |
| 34 | cytidine deamination (GO:0009972) | 3.47084012 |
| 35 | cytidine metabolic process (GO:0046087) | 3.47084012 |
| 36 | cytidine catabolic process (GO:0006216) | 3.47084012 |
| 37 | inner mitochondrial membrane organization (GO:0007007) | 3.46669125 |
| 38 | positive regulation of mitochondrial fission (GO:0090141) | 3.45143501 |
| 39 | neuronal action potential propagation (GO:0019227) | 3.43658445 |
| 40 | ATP biosynthetic process (GO:0006754) | 3.43250626 |
| 41 | respiratory chain complex IV assembly (GO:0008535) | 3.40818544 |
| 42 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.38992690 |
| 43 | hydrogen ion transmembrane transport (GO:1902600) | 3.38778535 |
| 44 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.38768949 |
| 45 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.38527939 |
| 46 | response to peptidoglycan (GO:0032494) | 3.34297255 |
| 47 | oxidative phosphorylation (GO:0006119) | 3.33640758 |
| 48 | metallo-sulfur cluster assembly (GO:0031163) | 3.29527954 |
| 49 | iron-sulfur cluster assembly (GO:0016226) | 3.29527954 |
| 50 | valine metabolic process (GO:0006573) | 3.29242178 |
| 51 | neutrophil activation (GO:0042119) | 3.27106503 |
| 52 | synaptic vesicle exocytosis (GO:0016079) | 3.23075100 |
| 53 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.22552601 |
| 54 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.22552601 |
| 55 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.22318964 |
| 56 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.20016166 |
| 57 | positive regulation of mast cell activation (GO:0033005) | 3.19857838 |
| 58 | regulation of mitochondrial translation (GO:0070129) | 3.19692715 |
| 59 | granulocyte activation (GO:0036230) | 3.17017105 |
| 60 | inositol phosphate catabolic process (GO:0071545) | 3.15429960 |
| 61 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.14458884 |
| 62 | NADH metabolic process (GO:0006734) | 3.14356769 |
| 63 | regulation of B cell differentiation (GO:0045577) | 3.13176909 |
| 64 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.11896021 |
| 65 | positive regulation of mast cell degranulation (GO:0043306) | 3.08062809 |
| 66 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.08062809 |
| 67 | response to interferon-beta (GO:0035456) | 3.07275237 |
| 68 | regulation of regulatory T cell differentiation (GO:0045589) | 3.05185745 |
| 69 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.05157855 |
| 70 | cytochrome complex assembly (GO:0017004) | 3.04893019 |
| 71 | regulation of cilium movement (GO:0003352) | 3.04539169 |
| 72 | inositol phosphate dephosphorylation (GO:0046855) | 3.04505869 |
| 73 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.04505869 |
| 74 | myeloid cell activation involved in immune response (GO:0002275) | 3.02321256 |
| 75 | negative regulation of interleukin-12 production (GO:0032695) | 3.00358911 |
| 76 | proton transport (GO:0015992) | 2.99554471 |
| 77 | regulation of mast cell activation (GO:0033003) | 2.97392219 |
| 78 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.96157797 |
| 79 | hydrogen transport (GO:0006818) | 2.95259847 |
| 80 | regulation of protein kinase A signaling (GO:0010738) | 2.95172232 |
| 81 | positive thymic T cell selection (GO:0045059) | 2.93320343 |
| 82 | positive regulation of antigen processing and presentation (GO:0002579) | 2.90383850 |
| 83 | catecholamine transport (GO:0051937) | 2.89226186 |
| 84 | regulation of mast cell degranulation (GO:0043304) | 2.89189218 |
| 85 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.88085987 |
| 86 | detection of bacterium (GO:0016045) | 2.86069432 |
| 87 | termination of RNA polymerase III transcription (GO:0006386) | 2.84802034 |
| 88 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.84802034 |
| 89 | detection of other organism (GO:0098543) | 2.84688379 |
| 90 | protein neddylation (GO:0045116) | 2.82672668 |
| 91 | aerobic respiration (GO:0009060) | 2.81996350 |
| 92 | autophagic vacuole fusion (GO:0000046) | 2.81781488 |
| 93 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.81270688 |
| 94 | tricarboxylic acid cycle (GO:0006099) | 2.81165943 |
| 95 | regulation of gamma-delta T cell activation (GO:0046643) | 2.79579233 |
| 96 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.78717194 |
| 97 | calcium ion-dependent exocytosis (GO:0017156) | 2.78303915 |
| 98 | regulation of antigen processing and presentation (GO:0002577) | 2.78230333 |
| 99 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.77132983 |
| 100 | mast cell activation (GO:0045576) | 2.76258721 |
| 101 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.75144019 |
| 102 | leukocyte degranulation (GO:0043299) | 2.73242362 |
| 103 | acrosome reaction (GO:0007340) | 2.72517574 |
| 104 | regulation of germinal center formation (GO:0002634) | 2.71268704 |
| 105 | phospholipid scrambling (GO:0017121) | 2.70819292 |
| 106 | regulation of tolerance induction (GO:0002643) | 2.70736078 |
| 107 | transferrin transport (GO:0033572) | 2.70667862 |
| 108 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.70281354 |
| 109 | purine nucleotide salvage (GO:0032261) | 2.69352810 |
| 110 | actin nucleation (GO:0045010) | 2.66417709 |
| 111 | regulation of cellular respiration (GO:0043457) | 2.65984435 |
| 112 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.65671199 |
| 113 | microglial cell activation (GO:0001774) | 2.65100887 |
| 114 | cellular response to interferon-gamma (GO:0071346) | 2.63762778 |
| 115 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.63642694 |
| 116 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.63428526 |
| 117 | type I interferon signaling pathway (GO:0060337) | 2.62616977 |
| 118 | cellular response to type I interferon (GO:0071357) | 2.62616977 |
| 119 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.62002828 |
| 120 | protein localization to synapse (GO:0035418) | 2.61273955 |
| 121 | polyol catabolic process (GO:0046174) | 2.61260609 |
| 122 | regulation of B cell apoptotic process (GO:0002902) | 2.60961282 |
| 123 | positive regulation of type 2 immune response (GO:0002830) | 2.59460261 |
| 124 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.59428648 |
| 125 | organelle membrane fusion (GO:0090174) | 2.59357073 |
| 126 | aldehyde catabolic process (GO:0046185) | 2.58927548 |
| 127 | macrophage activation involved in immune response (GO:0002281) | 2.56830512 |
| 128 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.55956726 |
| 129 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.55956726 |
| 130 | modulation by symbiont of host immune response (GO:0052553) | 2.55956726 |
| 131 | positive regulation by symbiont of host defense response (GO:0052509) | 2.55956726 |
| 132 | modulation by symbiont of host defense response (GO:0052031) | 2.55956726 |
| 133 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.55956726 |
| 134 | response to type I interferon (GO:0034340) | 2.55940439 |
| 135 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.55861205 |
| 136 | peptidyl-arginine methylation (GO:0018216) | 2.55481529 |
| 137 | peptidyl-arginine N-methylation (GO:0035246) | 2.55481529 |
| 138 | peroxisome fission (GO:0016559) | 2.55253313 |
| 139 | regulation of mitochondrial fission (GO:0090140) | 2.55195422 |
| 140 | proteasome assembly (GO:0043248) | 2.54859427 |
| 141 | positive T cell selection (GO:0043368) | 2.53991563 |
| 142 | regulation of glutamate secretion (GO:0014048) | 2.52972584 |
| 143 | negative regulation of dendrite development (GO:2000171) | 2.52154103 |
| 144 | axonemal dynein complex assembly (GO:0070286) | 2.50760963 |
| 145 | neurotransmitter uptake (GO:0001504) | 2.50758788 |
| 146 | response to interferon-gamma (GO:0034341) | 2.49338258 |
| 147 | GTP biosynthetic process (GO:0006183) | 2.49058147 |
| 148 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.48608793 |
| 149 | ferric iron transport (GO:0015682) | 2.47530320 |
| 150 | trivalent inorganic cation transport (GO:0072512) | 2.47530320 |
| 151 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.47434373 |
| 152 | purine-containing compound salvage (GO:0043101) | 2.47121260 |
| 153 | L-phenylalanine metabolic process (GO:0006558) | 2.46021574 |
| 154 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.46021574 |
| 155 | T cell costimulation (GO:0031295) | 2.45866830 |
| 156 | detection of external biotic stimulus (GO:0098581) | 2.44567993 |
| 157 | regulation of coenzyme metabolic process (GO:0051196) | 2.43959324 |
| 158 | regulation of cofactor metabolic process (GO:0051193) | 2.43959324 |
| 159 | regulation of catecholamine metabolic process (GO:0042069) | 2.43760289 |
| 160 | regulation of dopamine metabolic process (GO:0042053) | 2.43760289 |
| 161 | B cell receptor signaling pathway (GO:0050853) | 2.43738982 |
| 162 | lymphocyte costimulation (GO:0031294) | 2.42378103 |
| 163 | respiratory burst (GO:0045730) | 2.42134221 |
| 164 | dopamine biosynthetic process (GO:0042416) | 2.42081053 |
| 165 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.41895118 |
| 166 | glutamate secretion (GO:0014047) | 2.41256359 |
| 167 | negative regulation of B cell proliferation (GO:0030889) | 2.41238884 |
| 168 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.40578655 |
| 169 | L-phenylalanine catabolic process (GO:0006559) | 2.40578655 |
| 170 | vocalization behavior (GO:0071625) | 2.39970503 |
| 171 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.39788100 |
| 172 | GDP-mannose metabolic process (GO:0019673) | 2.38779016 |
| 173 | epithelial cilium movement (GO:0003351) | 2.38574221 |
| 174 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.38509745 |
| 175 | histamine secretion (GO:0001821) | 2.38437427 |
| 176 | cellular ketone body metabolic process (GO:0046950) | 2.38337860 |
| 177 | behavioral response to cocaine (GO:0048148) | 2.38274623 |
| 178 | positive regulation of interleukin-17 production (GO:0032740) | 2.38049078 |
| 179 | leukocyte aggregation (GO:0070486) | 2.37513333 |
| 180 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.36719896 |
| 181 | Peyers patch development (GO:0048541) | 2.36719896 |
| 182 | sperm motility (GO:0030317) | 2.36689294 |
| 183 | histone arginine methylation (GO:0034969) | 2.36469476 |
| 184 | regulation of T cell tolerance induction (GO:0002664) | 2.36441985 |
| 185 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.36217868 |
| 186 | positive regulation of tolerance induction (GO:0002645) | 2.35459117 |
| 187 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.33327913 |
| 188 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.33112746 |
| 189 | T cell migration (GO:0072678) | 2.33098990 |
| 190 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.33075121 |
| 191 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.32890875 |
| 192 | NIK/NF-kappaB signaling (GO:0038061) | 2.32748649 |
| 193 | positive regulation of granulocyte differentiation (GO:0030854) | 2.31601360 |
| 194 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.31174269 |
| 195 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.29896480 |
| 196 | lymphocyte chemotaxis (GO:0048247) | 2.29552368 |
| 197 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.29533114 |
| 198 | tolerance induction (GO:0002507) | 2.28155701 |
| 199 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.27011642 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.56760878 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.73947260 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.60251772 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.22790031 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.77857897 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.41901212 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.31334299 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 3.28662273 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.18164296 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.92783707 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.82458562 |
| 12 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.74315642 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.65675388 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.63984811 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.58157507 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.47652774 |
| 17 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.46274626 |
| 18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.42631158 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.39808339 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.39648995 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.37888873 |
| 22 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.24692400 |
| 23 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.18662932 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.12182938 |
| 25 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.09681547 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.08345195 |
| 27 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.05870661 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03032828 |
| 29 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.02930338 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.01420277 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.95968760 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.92992097 |
| 33 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.89857693 |
| 34 | GATA3_26560356_Chip-Seq_TH2_Human | 1.80575345 |
| 35 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.75766459 |
| 36 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.75572266 |
| 37 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.75535320 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.71771704 |
| 39 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.70470607 |
| 40 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.69010688 |
| 41 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68755558 |
| 42 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68714062 |
| 43 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.67290320 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.65879750 |
| 45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.65675905 |
| 46 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.65250154 |
| 47 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.62569255 |
| 48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.62405539 |
| 49 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61262617 |
| 50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.60029462 |
| 51 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.59139144 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.58779687 |
| 53 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.55904041 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55364892 |
| 55 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.51748084 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51703964 |
| 57 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.51288728 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51250330 |
| 59 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.50851314 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46780003 |
| 61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.46048750 |
| 62 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.45860830 |
| 63 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.43909093 |
| 64 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.43187632 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.43081713 |
| 66 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.39859150 |
| 67 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.38224062 |
| 68 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.35566922 |
| 69 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.34454592 |
| 70 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.33043181 |
| 71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.31996884 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30252441 |
| 73 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.27695430 |
| 74 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.26575829 |
| 75 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.26082070 |
| 76 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25782125 |
| 77 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.23755287 |
| 78 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23401378 |
| 79 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.22113933 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21657324 |
| 81 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.20779047 |
| 82 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.20511019 |
| 83 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19627606 |
| 84 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18866813 |
| 85 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.17336866 |
| 86 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.17038975 |
| 87 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16291896 |
| 88 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.14664448 |
| 89 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14540196 |
| 90 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13822142 |
| 91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13786169 |
| 92 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.12111610 |
| 93 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.11558656 |
| 94 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.10414936 |
| 95 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.09942674 |
| 96 | MAF_26560356_Chip-Seq_TH1_Human | 1.09469196 |
| 97 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08109719 |
| 98 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.07392005 |
| 99 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.06977273 |
| 100 | GATA3_26560356_Chip-Seq_TH1_Human | 1.06430010 |
| 101 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06206423 |
| 102 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06072602 |
| 103 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.05853504 |
| 104 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.05031927 |
| 105 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05015313 |
| 106 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04881101 |
| 107 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04782869 |
| 108 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.04330728 |
| 109 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.04168629 |
| 110 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.03505527 |
| 111 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.03290485 |
| 112 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.03128947 |
| 113 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.02939594 |
| 114 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02662629 |
| 115 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.02576668 |
| 116 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02357234 |
| 117 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.01539999 |
| 118 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.00737814 |
| 119 | AR_20517297_ChIP-Seq_VCAP_Human | 1.00714951 |
| 120 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.00467279 |
| 121 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.00248838 |
| 122 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98634192 |
| 123 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98453751 |
| 124 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98453751 |
| 125 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98255083 |
| 126 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.98066325 |
| 127 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97649603 |
| 128 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.95806327 |
| 129 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.95726768 |
| 130 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.95625568 |
| 131 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.95422405 |
| 132 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.95054484 |
| 133 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.93549150 |
| 134 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.93113114 |
| 135 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.92970775 |
| 136 | P300_27268052_Chip-Seq_Bcells_Human | 0.91432781 |
| 137 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91259511 |
| 138 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.91174448 |
| 139 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89872064 |
| 140 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89638291 |
| 141 | KDM2B_26808549_Chip-Seq_REH_Human | 0.89552246 |
| 142 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.89407502 |
| 143 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.89407502 |
| 144 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89377620 |
| 145 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.89246838 |
| 146 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.89246838 |
| 147 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.89214196 |
| 148 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.88205117 |
| 149 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.88074562 |
| 150 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.87903179 |
| 151 | VDR_22108803_ChIP-Seq_LS180_Human | 0.87651774 |
| 152 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87469702 |
| 153 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.86819695 |
| 154 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86640734 |
| 155 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.86367998 |
| 156 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.86093447 |
| 157 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.86055277 |
| 158 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85665365 |
| 159 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.85657088 |
| 160 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.85614281 |
| 161 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.85386044 |
| 162 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84533836 |
| 163 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.84221175 |
| 164 | NCOR_22424771_ChIP-Seq_293T_Human | 0.83576922 |
| 165 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.83499722 |
| 166 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.82810983 |
| 167 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82078976 |
| 168 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.81558580 |
| 169 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.80419757 |
| 170 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.80173684 |
| 171 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.80059243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.12343715 |
| 2 | MP0003724_increased_susceptibility_to | 3.71737666 |
| 3 | MP0003880_abnormal_central_pattern | 3.69099988 |
| 4 | MP0001986_abnormal_taste_sensitivity | 3.32644087 |
| 5 | MP0005671_abnormal_response_to | 3.24382872 |
| 6 | MP0009785_altered_susceptibility_to | 2.95353064 |
| 7 | MP0006276_abnormal_autonomic_nervous | 2.83115962 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.77657917 |
| 9 | MP0002736_abnormal_nociception_after | 2.70344368 |
| 10 | MP0003436_decreased_susceptibility_to | 2.69158780 |
| 11 | MP0004270_analgesia | 2.64662643 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.62788240 |
| 13 | MP0003303_peritoneal_inflammation | 2.62716804 |
| 14 | MP0004859_abnormal_synaptic_plasticity | 2.60281002 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.59621964 |
| 16 | MP0001800_abnormal_humoral_immune | 2.59210930 |
| 17 | MP0002139_abnormal_hepatobiliary_system | 2.50880961 |
| 18 | MP0005025_abnormal_response_to | 2.48893436 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.46404845 |
| 20 | MP0009379_abnormal_foot_pigmentation | 2.44490746 |
| 21 | MP0003635_abnormal_synaptic_transmissio | 2.42619278 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 2.42337369 |
| 23 | MP0005410_abnormal_fertilization | 2.41918869 |
| 24 | MP0002419_abnormal_innate_immunity | 2.37231197 |
| 25 | MP0002723_abnormal_immune_serum | 2.36784142 |
| 26 | MP0001790_abnormal_immune_system | 2.35478385 |
| 27 | MP0005387_immune_system_phenotype | 2.35478385 |
| 28 | MP0009745_abnormal_behavioral_response | 2.34551606 |
| 29 | MP0002452_abnormal_antigen_presenting | 2.32628058 |
| 30 | MP0006082_CNS_inflammation | 2.29205361 |
| 31 | MP0001905_abnormal_dopamine_level | 2.28808355 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 2.27253979 |
| 33 | MP0005464_abnormal_platelet_physiology | 2.26778350 |
| 34 | MP0001819_abnormal_immune_cell | 2.23340968 |
| 35 | MP0002420_abnormal_adaptive_immunity | 2.23103987 |
| 36 | MP0001529_abnormal_vocalization | 2.22045524 |
| 37 | MP0002272_abnormal_nervous_system | 2.17418122 |
| 38 | MP0006035_abnormal_mitochondrial_morpho | 2.16167385 |
| 39 | MP0002822_catalepsy | 2.14181581 |
| 40 | MP0000685_abnormal_immune_system | 2.11651558 |
| 41 | MP0009046_muscle_twitch | 2.10169425 |
| 42 | MP0002734_abnormal_mechanical_nocicepti | 2.02763154 |
| 43 | MP0001501_abnormal_sleep_pattern | 2.01790595 |
| 44 | MP0002064_seizures | 2.01139222 |
| 45 | MP0005085_abnormal_gallbladder_physiolo | 2.00781452 |
| 46 | MP0002733_abnormal_thermal_nociception | 1.99715421 |
| 47 | MP0002876_abnormal_thyroid_physiology | 1.99587235 |
| 48 | MP0005360_urolithiasis | 1.92477156 |
| 49 | MP0005365_abnormal_bile_salt | 1.91155000 |
| 50 | MP0001984_abnormal_olfaction | 1.89899298 |
| 51 | MP0002396_abnormal_hematopoietic_system | 1.88062559 |
| 52 | MP0002837_dystrophic_cardiac_calcinosis | 1.84986368 |
| 53 | MP0002572_abnormal_emotion/affect_behav | 1.82932827 |
| 54 | MP0001970_abnormal_pain_threshold | 1.78083044 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.77717509 |
| 56 | MP0009764_decreased_sensitivity_to | 1.77703774 |
| 57 | MP0002138_abnormal_hepatobiliary_system | 1.75505565 |
| 58 | MP0002398_abnormal_bone_marrow | 1.75462307 |
| 59 | MP0009697_abnormal_copulation | 1.74745959 |
| 60 | MP0000716_abnormal_immune_system | 1.72453454 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.71613831 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.70994076 |
| 63 | MP0002063_abnormal_learning/memory/cond | 1.70655040 |
| 64 | MP0002132_abnormal_respiratory_system | 1.68190843 |
| 65 | MP0002405_respiratory_system_inflammati | 1.67632900 |
| 66 | MP0001188_hyperpigmentation | 1.61927282 |
| 67 | MP0004147_increased_porphyrin_level | 1.61804000 |
| 68 | MP0002067_abnormal_sensory_capabilities | 1.61180466 |
| 69 | MP0000689_abnormal_spleen_morphology | 1.61052822 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 1.58564028 |
| 71 | MP0001853_heart_inflammation | 1.58474251 |
| 72 | MP0008469_abnormal_protein_level | 1.52533807 |
| 73 | MP0004142_abnormal_muscle_tone | 1.49046144 |
| 74 | MP0002722_abnormal_immune_system | 1.43644741 |
| 75 | MP0002429_abnormal_blood_cell | 1.41543922 |
| 76 | MP0005535_abnormal_body_temperature | 1.39384335 |
| 77 | MP0001545_abnormal_hematopoietic_system | 1.37888880 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 1.37888880 |
| 79 | MP0001533_abnormal_skeleton_physiology | 1.37554007 |
| 80 | MP0002254_reproductive_system_inflammat | 1.37415826 |
| 81 | MP0001440_abnormal_grooming_behavior | 1.37199504 |
| 82 | MP0008872_abnormal_physiological_respon | 1.37071523 |
| 83 | MP0003763_abnormal_thymus_physiology | 1.36973237 |
| 84 | MP0005423_abnormal_somatic_nervous | 1.36203132 |
| 85 | MP0003075_altered_response_to | 1.35625295 |
| 86 | MP0004924_abnormal_behavior | 1.32154003 |
| 87 | MP0005386_behavior/neurological_phenoty | 1.32154003 |
| 88 | MP0001486_abnormal_startle_reflex | 1.30908492 |
| 89 | MP0003879_abnormal_hair_cell | 1.27998585 |
| 90 | MP0003866_abnormal_defecation | 1.27778189 |
| 91 | MP0003646_muscle_fatigue | 1.26904292 |
| 92 | MP0005379_endocrine/exocrine_gland_phen | 1.26451228 |
| 93 | MP0000465_gastrointestinal_hemorrhage | 1.24439332 |
| 94 | MP0008874_decreased_physiological_sensi | 1.17896567 |
| 95 | MP0002184_abnormal_innervation | 1.15273883 |
| 96 | MP0000703_abnormal_thymus_morphology | 1.12015708 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 1.10591807 |
| 98 | MP0009763_increased_sensitivity_to | 1.10591405 |
| 99 | MP0000372_irregular_coat_pigmentation | 1.09940934 |
| 100 | MP0002163_abnormal_gland_morphology | 1.07534673 |
| 101 | MP0005636_abnormal_mineral_homeostasis | 1.06664527 |
| 102 | MP0002557_abnormal_social/conspecific_i | 1.05056580 |
| 103 | MP0005166_decreased_susceptibility_to | 1.05036459 |
| 104 | MP0001764_abnormal_homeostasis | 1.03259401 |
| 105 | MP0000343_altered_response_to | 1.02711624 |
| 106 | MP0005646_abnormal_pituitary_gland | 1.02540460 |
| 107 | MP0005058_abnormal_lysosome_morphology | 1.02336306 |
| 108 | MP0003172_abnormal_lysosome_physiology | 1.00953146 |
| 109 | MP0008877_abnormal_DNA_methylation | 0.99268124 |
| 110 | MP0003329_amyloid_beta_deposits | 0.97046869 |
| 111 | MP0003806_abnormal_nucleotide_metabolis | 0.96887782 |
| 112 | MP0003698_abnormal_male_reproductive | 0.96887462 |
| 113 | MP0010329_abnormal_lipoprotein_level | 0.96463856 |
| 114 | MP0010386_abnormal_urinary_bladder | 0.92511365 |
| 115 | MP0002166_altered_tumor_susceptibility | 0.92355140 |
| 116 | MP0008004_abnormal_stomach_pH | 0.90957529 |
| 117 | MP0004484_altered_response_of | 0.89891866 |
| 118 | MP0000858_altered_metastatic_potential | 0.89526767 |
| 119 | MP0005310_abnormal_salivary_gland | 0.88922487 |
| 120 | MP0003718_maternal_effect | 0.88906986 |
| 121 | MP0001664_abnormal_digestion | 0.88772207 |
| 122 | MP0002009_preneoplasia | 0.88320347 |
| 123 | MP0008569_lethality_at_weaning | 0.87433071 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87426491 |
| 125 | MP0000358_abnormal_cell_content/ | 0.87322655 |
| 126 | MP0001502_abnormal_circadian_rhythm | 0.87099626 |
| 127 | MP0003195_calcinosis | 0.86879938 |
| 128 | MP0002229_neurodegeneration | 0.86150185 |
| 129 | MP0001873_stomach_inflammation | 0.85936487 |
| 130 | MP0005084_abnormal_gallbladder_morpholo | 0.85728937 |
| 131 | MP0009765_abnormal_xenobiotic_induced | 0.85619942 |
| 132 | MP0003011_delayed_dark_adaptation | 0.85318129 |
| 133 | MP0004145_abnormal_muscle_electrophysio | 0.84045246 |
| 134 | MP0003448_altered_tumor_morphology | 0.83528832 |
| 135 | MP0002066_abnormal_motor_capabilities/c | 0.83456448 |
| 136 | MP0003186_abnormal_redox_activity | 0.83221132 |
| 137 | MP0005647_abnormal_sex_gland | 0.83080304 |
| 138 | MP0003191_abnormal_cellular_cholesterol | 0.82806274 |
| 139 | MP0005645_abnormal_hypothalamus_physiol | 0.81708211 |
| 140 | MP0005319_abnormal_enzyme/_coenzyme | 0.80680916 |
| 141 | MP0002332_abnormal_exercise_endurance | 0.79897535 |
| 142 | MP0001929_abnormal_gametogenesis | 0.79840499 |
| 143 | MP0003868_abnormal_feces_composition | 0.79321108 |
| 144 | MP0005332_abnormal_amino_acid | 0.77677522 |
| 145 | MP0003252_abnormal_bile_duct | 0.74896241 |
| 146 | MP0001765_abnormal_ion_homeostasis | 0.74887550 |
| 147 | MP0008058_abnormal_DNA_repair | 0.74678391 |
| 148 | MP0003787_abnormal_imprinting | 0.74587227 |
| 149 | MP0005376_homeostasis/metabolism_phenot | 0.73903293 |
| 150 | MP0004947_skin_inflammation | 0.73476749 |
| 151 | MP0000751_myopathy | 0.73256092 |
| 152 | MP0000678_abnormal_parathyroid_gland | 0.73151579 |
| 153 | MP0003638_abnormal_response/metabolism_ | 0.72963697 |
| 154 | MP0000230_abnormal_systemic_arterial | 0.72167200 |
| 155 | MP0004036_abnormal_muscle_relaxation | 0.71906224 |
| 156 | MP0002102_abnormal_ear_morphology | 0.71782236 |
| 157 | MP0008873_increased_physiological_sensi | 0.71553101 |
| 158 | MP0002019_abnormal_tumor_incidence | 0.71314358 |
| 159 | MP0002693_abnormal_pancreas_physiology | 0.70654620 |
| 160 | MP0002909_abnormal_adrenal_gland | 0.70634376 |
| 161 | MP0009643_abnormal_urine_homeostasis | 0.70006790 |
| 162 | MP0001663_abnormal_digestive_system | 0.68474439 |
| 163 | MP0005075_abnormal_melanosome_morpholog | 0.66659141 |
| 164 | MP0005083_abnormal_biliary_tract | 0.65717100 |
| 165 | MP0004811_abnormal_neuron_physiology | 0.65586924 |
| 166 | MP0005266_abnormal_metabolism | 0.65569099 |
| 167 | MP0002069_abnormal_eating/drinking_beha | 0.64840824 |
| 168 | MP0005551_abnormal_eye_electrophysiolog | 0.64726770 |
| 169 | MP0005389_reproductive_system_phenotype | 0.64440709 |
| 170 | MP0002998_abnormal_bone_remodeling | 0.64040930 |
| 171 | MP0000955_abnormal_spinal_cord | 0.63036627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.11471409 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.76567979 |
| 3 | Mitochondrial inheritance (HP:0001427) | 4.70715132 |
| 4 | Hepatocellular necrosis (HP:0001404) | 4.46470925 |
| 5 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.44574603 |
| 6 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.44574603 |
| 7 | Increased intramyocellular lipid droplets (HP:0012240) | 4.31017133 |
| 8 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.24343566 |
| 9 | Acute encephalopathy (HP:0006846) | 4.23464069 |
| 10 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 4.05562759 |
| 11 | Progressive macrocephaly (HP:0004481) | 4.04600800 |
| 12 | Focal motor seizures (HP:0011153) | 4.00972712 |
| 13 | Increased CSF lactate (HP:0002490) | 3.99025016 |
| 14 | Hypothermia (HP:0002045) | 3.96743445 |
| 15 | Hepatic necrosis (HP:0002605) | 3.84850603 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.77398648 |
| 17 | Increased muscle lipid content (HP:0009058) | 3.71933269 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.64141962 |
| 19 | Stomatitis (HP:0010280) | 3.61202173 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.52609834 |
| 21 | Myokymia (HP:0002411) | 3.52379064 |
| 22 | Increased hepatocellular lipid droplets (HP:0006565) | 3.52079299 |
| 23 | Atonic seizures (HP:0010819) | 3.49546765 |
| 24 | Abnormal hair whorl (HP:0010721) | 3.47610013 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.45515550 |
| 26 | Obstructive lung disease (HP:0006536) | 3.45515550 |
| 27 | Ragged-red muscle fibers (HP:0003200) | 3.41364577 |
| 28 | Absent/shortened dynein arms (HP:0200106) | 3.39822407 |
| 29 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.39822407 |
| 30 | Lactic acidosis (HP:0003128) | 3.34495620 |
| 31 | Lipid accumulation in hepatocytes (HP:0006561) | 3.23274351 |
| 32 | Renal Fanconi syndrome (HP:0001994) | 3.17873779 |
| 33 | Cerebral edema (HP:0002181) | 3.17339696 |
| 34 | Abnormality of macrophages (HP:0004311) | 3.10045410 |
| 35 | Myositis (HP:0100614) | 3.09846293 |
| 36 | Meningitis (HP:0001287) | 3.05171606 |
| 37 | Abnormality of the prostate (HP:0008775) | 3.01972251 |
| 38 | Visual hallucinations (HP:0002367) | 2.93681073 |
| 39 | Exercise intolerance (HP:0003546) | 2.92249899 |
| 40 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.92233078 |
| 41 | Eczematoid dermatitis (HP:0000976) | 2.87189894 |
| 42 | Febrile seizures (HP:0002373) | 2.84845598 |
| 43 | Vasculitis (HP:0002633) | 2.84250800 |
| 44 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.83697341 |
| 45 | 3-Methylglutaconic aciduria (HP:0003535) | 2.83302997 |
| 46 | Optic neuritis (HP:0100653) | 2.81406628 |
| 47 | Retrobulbar optic neuritis (HP:0100654) | 2.81406628 |
| 48 | Increased serum lactate (HP:0002151) | 2.75746418 |
| 49 | Chronic otitis media (HP:0000389) | 2.72733859 |
| 50 | Generalized aminoaciduria (HP:0002909) | 2.70761370 |
| 51 | Focal seizures (HP:0007359) | 2.68732368 |
| 52 | Orchitis (HP:0100796) | 2.67923132 |
| 53 | Petechiae (HP:0000967) | 2.67266523 |
| 54 | Recurrent skin infections (HP:0001581) | 2.66398973 |
| 55 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.66137781 |
| 56 | Abnormal ciliary motility (HP:0012262) | 2.65856350 |
| 57 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.63902519 |
| 58 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.61336262 |
| 59 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.61336262 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.58638925 |
| 61 | Mediastinal lymphadenopathy (HP:0100721) | 2.58116256 |
| 62 | Chronic sinusitis (HP:0011109) | 2.57893682 |
| 63 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.57513353 |
| 64 | Dialeptic seizures (HP:0011146) | 2.55135582 |
| 65 | Optic disc pallor (HP:0000543) | 2.55000187 |
| 66 | Abnormal number of erythroid precursors (HP:0012131) | 2.54507772 |
| 67 | Increased IgM level (HP:0003496) | 2.53405524 |
| 68 | Medial flaring of the eyebrow (HP:0010747) | 2.51707722 |
| 69 | Respiratory failure (HP:0002878) | 2.49806316 |
| 70 | Abnormality of renal resorption (HP:0011038) | 2.48323275 |
| 71 | Recurrent fungal infections (HP:0002841) | 2.48140231 |
| 72 | Leukodystrophy (HP:0002415) | 2.46134179 |
| 73 | Encephalitis (HP:0002383) | 2.45304233 |
| 74 | Exertional dyspnea (HP:0002875) | 2.44675558 |
| 75 | Respiratory difficulties (HP:0002880) | 2.40994331 |
| 76 | Absence seizures (HP:0002121) | 2.40701279 |
| 77 | Epileptic encephalopathy (HP:0200134) | 2.39975995 |
| 78 | Neuroendocrine neoplasm (HP:0100634) | 2.39544838 |
| 79 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.39385951 |
| 80 | Prolonged partial thromboplastin time (HP:0003645) | 2.36052365 |
| 81 | Spastic paraparesis (HP:0002313) | 2.33352794 |
| 82 | Urticaria (HP:0001025) | 2.33093851 |
| 83 | Hemoptysis (HP:0002105) | 2.31341338 |
| 84 | Emotional lability (HP:0000712) | 2.29990155 |
| 85 | Recurrent sinusitis (HP:0011108) | 2.28630761 |
| 86 | Cholecystitis (HP:0001082) | 2.28024289 |
| 87 | Abnormal gallbladder physiology (HP:0012438) | 2.28024289 |
| 88 | Agammaglobulinemia (HP:0004432) | 2.27581458 |
| 89 | Pheochromocytoma (HP:0002666) | 2.25982827 |
| 90 | Congenital primary aphakia (HP:0007707) | 2.25894363 |
| 91 | Gait imbalance (HP:0002141) | 2.25603571 |
| 92 | Autoimmune hemolytic anemia (HP:0001890) | 2.24016337 |
| 93 | Lethargy (HP:0001254) | 2.21894771 |
| 94 | Progressive cerebellar ataxia (HP:0002073) | 2.21364856 |
| 95 | Scanning speech (HP:0002168) | 2.20419058 |
| 96 | Panhypogammaglobulinemia (HP:0003139) | 2.19595470 |
| 97 | Abnormality of T cell number (HP:0011839) | 2.18794891 |
| 98 | Abnormality of the pleura (HP:0002103) | 2.18219412 |
| 99 | Hypoglycemic seizures (HP:0002173) | 2.17327931 |
| 100 | Hyperventilation (HP:0002883) | 2.16907185 |
| 101 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.16389288 |
| 102 | Recurrent cutaneous fungal infections (HP:0011370) | 2.16389288 |
| 103 | Prolonged bleeding time (HP:0003010) | 2.15841947 |
| 104 | Abnormality of T cells (HP:0002843) | 2.15706920 |
| 105 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.15226581 |
| 106 | Male infertility (HP:0003251) | 2.14860086 |
| 107 | Progressive inability to walk (HP:0002505) | 2.14650227 |
| 108 | Abnormality of the nasal mucosa (HP:0000433) | 2.14180529 |
| 109 | Gastrointestinal infarctions (HP:0005244) | 2.12776604 |
| 110 | Generalized tonic-clonic seizures (HP:0002069) | 2.12153948 |
| 111 | Recurrent bronchitis (HP:0002837) | 2.11986387 |
| 112 | Progressive muscle weakness (HP:0003323) | 2.11885260 |
| 113 | Autoimmune thrombocytopenia (HP:0001973) | 2.11602416 |
| 114 | Stomach cancer (HP:0012126) | 2.11483975 |
| 115 | Alveolar cell carcinoma (HP:0006519) | 2.08812294 |
| 116 | T lymphocytopenia (HP:0005403) | 2.08571328 |
| 117 | Esotropia (HP:0000565) | 2.08445691 |
| 118 | Epistaxis (HP:0000421) | 2.08194391 |
| 119 | Infertility (HP:0000789) | 2.07941352 |
| 120 | Nephrogenic diabetes insipidus (HP:0009806) | 2.07914728 |
| 121 | Gaze-evoked nystagmus (HP:0000640) | 2.07085170 |
| 122 | Poor suck (HP:0002033) | 2.07001575 |
| 123 | Gangrene (HP:0100758) | 2.06767127 |
| 124 | Abnormality of glycolipid metabolism (HP:0010969) | 2.06500951 |
| 125 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.06500951 |
| 126 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.06500951 |
| 127 | Mutism (HP:0002300) | 2.06385919 |
| 128 | Pulmonary fibrosis (HP:0002206) | 2.06100396 |
| 129 | Hypobetalipoproteinemia (HP:0003563) | 2.05741885 |
| 130 | Delusions (HP:0000746) | 2.05006954 |
| 131 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.02630008 |
| 132 | Skin rash (HP:0000988) | 2.02446392 |
| 133 | Tetany (HP:0001281) | 2.01653940 |
| 134 | Abnormality of T cell physiology (HP:0011840) | 2.01526204 |
| 135 | Pulmonary embolism (HP:0002204) | 2.01417804 |
| 136 | Hypercortisolism (HP:0001578) | 2.00320761 |
| 137 | Chest pain (HP:0100749) | 1.99101009 |
| 138 | Polyneuropathy (HP:0001271) | 1.97814053 |
| 139 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.97787192 |
| 140 | Bronchiectasis (HP:0002110) | 1.97527350 |
| 141 | Hypochromic microcytic anemia (HP:0004840) | 1.97385643 |
| 142 | Systemic lupus erythematosus (HP:0002725) | 1.96504167 |
| 143 | Abnormality of B cell number (HP:0010975) | 1.95343596 |
| 144 | Purpura (HP:0000979) | 1.94979961 |
| 145 | Pancreatic fibrosis (HP:0100732) | 1.93943572 |
| 146 | Hyperphosphaturia (HP:0003109) | 1.92084316 |
| 147 | Keratoconjunctivitis sicca (HP:0001097) | 1.91423870 |
| 148 | Vacuolated lymphocytes (HP:0001922) | 1.91078175 |
| 149 | Ketoacidosis (HP:0001993) | 1.90676180 |
| 150 | CNS demyelination (HP:0007305) | 1.90050597 |
| 151 | Poor coordination (HP:0002370) | 1.88739631 |
| 152 | Anorexia (HP:0002039) | 1.88551221 |
| 153 | Nasal polyposis (HP:0100582) | 1.87676278 |
| 154 | CNS hypomyelination (HP:0003429) | 1.86480731 |
| 155 | Rhinitis (HP:0012384) | 1.84970326 |
| 156 | Progressive external ophthalmoplegia (HP:0000590) | 1.84889493 |
| 157 | Postural tremor (HP:0002174) | 1.83742980 |
| 158 | Nonprogressive disorder (HP:0003680) | 1.81642981 |
| 159 | Decreased muscle mass (HP:0003199) | 1.81038273 |
| 160 | Cerebral hemorrhage (HP:0001342) | 1.79518964 |
| 161 | Inability to walk (HP:0002540) | 1.79312971 |
| 162 | Anxiety (HP:0000739) | 1.77041525 |
| 163 | Hypokinesia (HP:0002375) | 1.76412537 |
| 164 | Reduced antithrombin III activity (HP:0001976) | 1.76092204 |
| 165 | Palpitations (HP:0001962) | 1.75913126 |
| 166 | Abnormality of urine glucose concentration (HP:0011016) | 1.73410711 |
| 167 | Glycosuria (HP:0003076) | 1.73410711 |
| 168 | X-linked dominant inheritance (HP:0001423) | 1.72801952 |
| 169 | Genital tract atresia (HP:0001827) | 1.72078711 |
| 170 | Bradykinesia (HP:0002067) | 1.70056775 |
| 171 | Upper motor neuron abnormality (HP:0002127) | 1.69427665 |
| 172 | Neoplasm of head and neck (HP:0012288) | 1.68683167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 5.37553730 |
| 2 | MUSK | 4.06313442 |
| 3 | MAP2K7 | 3.05574585 |
| 4 | CASK | 2.67281707 |
| 5 | CDK19 | 2.55530835 |
| 6 | MST4 | 2.49232321 |
| 7 | GRK5 | 2.45295209 |
| 8 | MAP3K4 | 2.41034658 |
| 9 | NTRK3 | 2.29813282 |
| 10 | ARAF | 2.27969485 |
| 11 | NME2 | 2.20210517 |
| 12 | MAP2K4 | 2.07410178 |
| 13 | IKBKE | 2.07024224 |
| 14 | PDK3 | 2.06549031 |
| 15 | PDK4 | 2.06549031 |
| 16 | NME1 | 2.06314203 |
| 17 | MAP3K9 | 2.04373151 |
| 18 | RIPK4 | 2.01504343 |
| 19 | BLK | 1.92966339 |
| 20 | IKBKB | 1.89974597 |
| 21 | TLK1 | 1.87684224 |
| 22 | MAP4K2 | 1.86465397 |
| 23 | MAPKAPK5 | 1.79584308 |
| 24 | IRAK4 | 1.72820756 |
| 25 | CCNB1 | 1.72058826 |
| 26 | CSF1R | 1.71718381 |
| 27 | KDR | 1.67027567 |
| 28 | ADRBK2 | 1.60679790 |
| 29 | PINK1 | 1.58775783 |
| 30 | TYK2 | 1.57518234 |
| 31 | MINK1 | 1.56476100 |
| 32 | TBK1 | 1.54592276 |
| 33 | NUAK1 | 1.53963824 |
| 34 | ZAK | 1.53205951 |
| 35 | CSK | 1.52178518 |
| 36 | LYN | 1.47347818 |
| 37 | MYLK | 1.45454965 |
| 38 | PNCK | 1.42214812 |
| 39 | MAP3K14 | 1.39523337 |
| 40 | STK16 | 1.37713317 |
| 41 | ZAP70 | 1.36494431 |
| 42 | ITK | 1.31816228 |
| 43 | DAPK1 | 1.26362349 |
| 44 | VRK2 | 1.25923821 |
| 45 | AKT3 | 1.25827146 |
| 46 | MST1R | 1.25589954 |
| 47 | SYK | 1.24744228 |
| 48 | BRAF | 1.23924862 |
| 49 | PLK2 | 1.23882957 |
| 50 | MAP3K13 | 1.22951941 |
| 51 | FES | 1.22545978 |
| 52 | TESK2 | 1.20913213 |
| 53 | EPHA4 | 1.17248722 |
| 54 | KSR2 | 1.16083689 |
| 55 | GRK7 | 1.15318677 |
| 56 | DAPK2 | 1.13772003 |
| 57 | PRKCQ | 1.09769390 |
| 58 | CSNK1G3 | 1.08758981 |
| 59 | MAP2K3 | 1.08675080 |
| 60 | CAMKK2 | 1.08485731 |
| 61 | EIF2AK3 | 1.07628550 |
| 62 | HCK | 1.06918867 |
| 63 | LCK | 0.99381033 |
| 64 | MAPK13 | 0.98771949 |
| 65 | PDK1 | 0.96190537 |
| 66 | TNIK | 0.94111802 |
| 67 | MARK3 | 0.92793697 |
| 68 | CSNK1G2 | 0.92694186 |
| 69 | GRK6 | 0.92148594 |
| 70 | FLT3 | 0.90134202 |
| 71 | MAPKAPK3 | 0.90042878 |
| 72 | JAK2 | 0.87918074 |
| 73 | PDK2 | 0.85555480 |
| 74 | MAP3K3 | 0.85268278 |
| 75 | PIK3CG | 0.83540409 |
| 76 | MAP2K6 | 0.82148286 |
| 77 | INSRR | 0.82130034 |
| 78 | TAOK2 | 0.82007052 |
| 79 | BMPR2 | 0.77489114 |
| 80 | PRKCG | 0.75932850 |
| 81 | JAK3 | 0.75716359 |
| 82 | PIM1 | 0.75503776 |
| 83 | CAMK2A | 0.75495433 |
| 84 | RPS6KB1 | 0.75415040 |
| 85 | PDPK1 | 0.74928051 |
| 86 | OXSR1 | 0.74764747 |
| 87 | KIT | 0.73991891 |
| 88 | ERBB4 | 0.73454406 |
| 89 | STK39 | 0.69761537 |
| 90 | CSNK1G1 | 0.69745426 |
| 91 | TAOK3 | 0.68526801 |
| 92 | MAP4K1 | 0.68245207 |
| 93 | BCKDK | 0.66371680 |
| 94 | TEC | 0.65324645 |
| 95 | TSSK6 | 0.64263209 |
| 96 | MAP3K11 | 0.64189728 |
| 97 | SIK3 | 0.63719014 |
| 98 | ACVR1B | 0.63640712 |
| 99 | PLK4 | 0.63472939 |
| 100 | FRK | 0.62780282 |
| 101 | RAF1 | 0.61726445 |
| 102 | NTRK1 | 0.60810466 |
| 103 | TNK2 | 0.60628885 |
| 104 | CAMK1 | 0.59359477 |
| 105 | PTK2B | 0.59116330 |
| 106 | WNK4 | 0.57219289 |
| 107 | MAP3K1 | 0.56853345 |
| 108 | BTK | 0.56722790 |
| 109 | TESK1 | 0.54763742 |
| 110 | MAPK4 | 0.54473493 |
| 111 | ADRBK1 | 0.53727502 |
| 112 | VRK1 | 0.53573150 |
| 113 | TAOK1 | 0.52985779 |
| 114 | SGK2 | 0.52748441 |
| 115 | MAPK15 | 0.52477537 |
| 116 | HIPK2 | 0.52018204 |
| 117 | CAMK2B | 0.51063898 |
| 118 | CAMK2G | 0.50995720 |
| 119 | PRKG2 | 0.50908429 |
| 120 | NTRK2 | 0.50862222 |
| 121 | BUB1 | 0.50630431 |
| 122 | MATK | 0.49923066 |
| 123 | JAK1 | 0.49237829 |
| 124 | KSR1 | 0.49214496 |
| 125 | ABL2 | 0.49126924 |
| 126 | ERN1 | 0.46853868 |
| 127 | MAP3K6 | 0.46528224 |
| 128 | LMTK2 | 0.46527812 |
| 129 | RPS6KA5 | 0.45893373 |
| 130 | CDK5 | 0.45016574 |
| 131 | ABL1 | 0.44804415 |
| 132 | LRRK2 | 0.44392980 |
| 133 | MOS | 0.43903875 |
| 134 | STK4 | 0.42647572 |
| 135 | PRKCD | 0.40709217 |
| 136 | BMPR1B | 0.40496107 |
| 137 | SCYL2 | 0.40486003 |
| 138 | GRK1 | 0.39889203 |
| 139 | PRKACA | 0.39874092 |
| 140 | IGF1R | 0.38623429 |
| 141 | CSNK1A1L | 0.38401033 |
| 142 | CAMK2D | 0.38241290 |
| 143 | STK11 | 0.37565407 |
| 144 | SGK223 | 0.37222029 |
| 145 | SGK494 | 0.37222029 |
| 146 | MAPK12 | 0.36955593 |
| 147 | ERBB3 | 0.36106066 |
| 148 | FGR | 0.36012052 |
| 149 | FYN | 0.34895944 |
| 150 | TXK | 0.34677246 |
| 151 | MAP3K5 | 0.34542371 |
| 152 | STK10 | 0.34388911 |
| 153 | PIM2 | 0.33214819 |
| 154 | IRAK1 | 0.32376941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.87913636 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.25527708 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 4.12292970 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.01561790 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.97060912 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.90822061 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.45186368 |
| 8 | Alzheimers disease_Homo sapiens_hsa05010 | 3.16579806 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.11219025 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.93871528 |
| 11 | Huntingtons disease_Homo sapiens_hsa05016 | 2.91520547 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.69597748 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.66927429 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 2.52915947 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.51904546 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.42697328 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.38989404 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.28189129 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.26131044 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.24641835 |
| 21 | Nicotine addiction_Homo sapiens_hsa05033 | 2.17181724 |
| 22 | Ribosome_Homo sapiens_hsa03010 | 2.09333535 |
| 23 | Proteasome_Homo sapiens_hsa03050 | 2.03146420 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.97965281 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.80432488 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.80317436 |
| 27 | RNA polymerase_Homo sapiens_hsa03020 | 1.78300493 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.76448299 |
| 29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.76366267 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.69778551 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.69589443 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.69430458 |
| 33 | Olfactory transduction_Homo sapiens_hsa04740 | 1.59845850 |
| 34 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.53103370 |
| 35 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.51395791 |
| 36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.49952440 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.45491224 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.43810679 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.42602110 |
| 40 | Long-term potentiation_Homo sapiens_hsa04720 | 1.41738523 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.35802336 |
| 42 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.31005029 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.30327884 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30128081 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30119340 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.26126085 |
| 47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.24233570 |
| 48 | GABAergic synapse_Homo sapiens_hsa04727 | 1.22686066 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21800059 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.20461734 |
| 51 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.16039201 |
| 52 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.14458152 |
| 53 | Circadian entrainment_Homo sapiens_hsa04713 | 1.11685849 |
| 54 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.10887486 |
| 55 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.08557570 |
| 56 | Morphine addiction_Homo sapiens_hsa05032 | 1.07747313 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 1.06559202 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06326669 |
| 59 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.06265564 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05893769 |
| 61 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.05712167 |
| 62 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.05272600 |
| 63 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.04068243 |
| 64 | Salivary secretion_Homo sapiens_hsa04970 | 1.02928698 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01298679 |
| 66 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00299085 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.99213152 |
| 68 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.98738617 |
| 69 | Protein export_Homo sapiens_hsa03060 | 0.98019683 |
| 70 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.96217301 |
| 71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96098174 |
| 72 | Influenza A_Homo sapiens_hsa05164 | 0.94893001 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.93996410 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92400371 |
| 75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90134496 |
| 76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.87269675 |
| 77 | Insulin secretion_Homo sapiens_hsa04911 | 0.86406074 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85214304 |
| 79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.84410301 |
| 80 | Measles_Homo sapiens_hsa05162 | 0.84360951 |
| 81 | Malaria_Homo sapiens_hsa05144 | 0.82535098 |
| 82 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81626440 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.81346019 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81299196 |
| 85 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79820795 |
| 86 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.79721362 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.79516148 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.79459957 |
| 89 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.79439293 |
| 90 | Histidine metabolism_Homo sapiens_hsa00340 | 0.78751615 |
| 91 | Renin secretion_Homo sapiens_hsa04924 | 0.77975922 |
| 92 | Lysosome_Homo sapiens_hsa04142 | 0.77348986 |
| 93 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.77021226 |
| 94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75478854 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.75339302 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75329830 |
| 97 | Pertussis_Homo sapiens_hsa05133 | 0.73925599 |
| 98 | Purine metabolism_Homo sapiens_hsa00230 | 0.70927158 |
| 99 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.70446077 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68947972 |
| 101 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.68672868 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68126640 |
| 103 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67424618 |
| 104 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66809906 |
| 105 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.65581320 |
| 106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64916745 |
| 107 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64797864 |
| 108 | Long-term depression_Homo sapiens_hsa04730 | 0.64513950 |
| 109 | Homologous recombination_Homo sapiens_hsa03440 | 0.63887138 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63804842 |
| 111 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.59764904 |
| 112 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.58738213 |
| 113 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58710040 |
| 114 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56093294 |
| 115 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.55947791 |
| 116 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55234028 |
| 117 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54912405 |
| 118 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54742356 |
| 119 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.54155597 |
| 120 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53794631 |
| 121 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.53768050 |
| 122 | Phototransduction_Homo sapiens_hsa04744 | 0.53605377 |
| 123 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.53419248 |
| 124 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53347396 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51275892 |
| 126 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50637902 |
| 127 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.50026575 |
| 128 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.49030294 |
| 129 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48415703 |
| 130 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47644859 |
| 131 | Cocaine addiction_Homo sapiens_hsa05030 | 0.46809088 |
| 132 | Shigellosis_Homo sapiens_hsa05131 | 0.46552457 |
| 133 | Salmonella infection_Homo sapiens_hsa05132 | 0.46228240 |
| 134 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.46049118 |
| 135 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45627484 |
| 136 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45496654 |
| 137 | Mismatch repair_Homo sapiens_hsa03430 | 0.44596129 |
| 138 | Platelet activation_Homo sapiens_hsa04611 | 0.43483548 |
| 139 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43429799 |
| 140 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43032538 |
| 141 | Bile secretion_Homo sapiens_hsa04976 | 0.42974013 |
| 142 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41682030 |
| 143 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39109481 |
| 144 | Other glycan degradation_Homo sapiens_hsa00511 | 0.38733466 |
| 145 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36908389 |
| 146 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33344550 |
| 147 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.32376181 |
| 148 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.31087403 |
| 149 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.30204261 |
| 150 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.29974771 |
| 151 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29346269 |
| 152 | ABC transporters_Homo sapiens_hsa02010 | 0.28833506 |
| 153 | Retinol metabolism_Homo sapiens_hsa00830 | 0.28824879 |
| 154 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.26317366 |
| 155 | Base excision repair_Homo sapiens_hsa03410 | 0.25204748 |
| 156 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24474939 |
| 157 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.24391066 |
| 158 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23746676 |
| 159 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.21306626 |
| 160 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.21009014 |
| 161 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.18251286 |
| 162 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18149630 |
| 163 | RNA degradation_Homo sapiens_hsa03018 | 0.17599026 |

